Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China

American Journal of Tropical Medicine and Hygiene

Volumn 72, Issue 4, 2005, Pages 410-414

  Wang, Xinhua ^a   Mu, Jianbing ^b   Li, Guoqiao ^a   Chen, Peiquan ^a   Guo, Xingbo ^a   Fu, Linchun ^a   Chen, Lin ^a   Su, Xinzhuan ^b   Wellems, Thomas E ^b  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; CHLOROQUINE; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER 76T PROTEIN; PROTOZOAL DNA; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; MEMBRANE PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PRIMER DNA; PROTOZOAL PROTEIN;

ARTICLE; BLOOD SAMPLING; CHINA; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG WITHDRAWAL; HEALTH CARE POLICY; HUMAN; IN VITRO STUDY; MALARIA; MONITORING; NONHUMAN; PLASMODIUM FALCIPARUM; PREVALENCE; ANIMAL; CODON; DRUG RESISTANCE; GENETIC MARKER; GENETICS; MALARIA FALCIPARUM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; BASE SEQUENCE; CHINA; CHLOROQUINE; CODON; DNA PRIMERS; DRUG RESISTANCE; GENETIC MARKERS; HUMANS; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; PROTOZOAN PROTEINS;

EID: 18944368638     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.72.410     Document Type: Article

References (26)

1. Chen L, Dai ZR, Cai XZ, Waki S, 1998. Epidemic history of drug-resistant falciparum malaria in Hainan province. J Guangzhou Univ Traditional Chin Med 15: 35-37.
2. Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qiu CP, Cai XZ, Ling CF, Liang AH, Tang Y, 1992. Alteration in resistance of Plasmodium falciparum to chloroquine after cessation of chloroquine medication for twelve years. Chin Parasitol Parasitic Dis 10: 241-244.
3. Liu DQ, Liu RJ, Ren DX, Gao DQ, Zhang CY, Qui CP, Cai XZ, Ling CF, Song AH, Tang X, 1995. Change in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bull World Health Organ 73: 483-486.
4. Chen PQ, He KR, Peng NZ, Ou FZ, Fu LC, 2003. In vitro sensitivity of Plasmodium falciparum to chloroquine in Dongfang city in Hainan province. J Trop Med 3: 167-168.
5. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
6. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, 2001. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344: 257-263.
7. Wellems TE, Plowe CV, 2001. Chloroquine-resistant malaria. J Infect Dis 184: 770-776.
8. Rieckmann KH, Campbell GH, Sax LJ, Mreme JE, 1978. Drug sensitivity of Plasmodium falciparum: an in-vitro microtechnique. Lancet 1: 22-23.
9. Liu DQ, Liu RJ, Zhang CY, Cai XZ, Tang X, Yang HL, Yang PF, Dong Y, 1996. Present status of the sensitivity of Plasmodium falciparum to antimalarials in China. Chin Parasitol Parasitic Dis 14: 37-41.
10. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ, 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418: 320-323.
11. Chen N, Kyle DE, Pasay C, Fowler EV, Baker J, Peters JM, Cheng Q, 2003. pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines. Antimicrob Agents Chemother 47: 3500-3505.
12. Johnson DJ, Fidock DA, Mungthin M, Lakshmanan V, Sidhu AB, Bray PG, Ward SA, 2004. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol Cell 15: 867-877.
13. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF, 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 202-203.
14. Wilson CM, Volkman SK, Thaithong S, Martin RK, Kyle DE, Milhous WK, Wirth DF, 1993. Amplification of pfmdr-1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 57: 151-160.
15. Haruki K, Bray PG, Ward SA, Hommel M, Ritchie GY, 1994. Chloroquine resistance of Plasmodium falciparum: further evidence for a lack of association with mutations of the pfmdr-1 gene. Trans R Soc Trop Med Hyg 88: 694.
16. Cox-Singh J, Singh B, Alias A, Abdullah MS, 1995. Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg 89: 436-437.
17. Chaiyaroj SC, Buranakiti A, Angkasekwinai P, Looaressuwan S, Cowman AF, 1999. Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand. Am J Trop Med Hyg 61: 780-783.
18. Kublin JG, Cortese JF, Njunju EM, Mukadam RA, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV, 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187: 1870-1875.
19. Expert Advisory Committee on Malaria, Ministry of Health, 2000. Malaria situation in the People's Republic of China in 1999. Chin Parasitol Parasitic Dis 18: 129-131.
20. Bruce MC, Donnelly CA, Alpers MP, Galinski MR, Barnwell JW, Walliker D, Day KP, 2000. Cross-species interactions between malaria parasites in humans. Science 287: 845-848.
21. Chen L, Qu F, Zhou Y, 1982. Field observations on the antimalarial piperaquine. Chin Med J 95: 281-286.
22. Basco LK, Ringwald P, 2003. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon. Antimicrob Agents Chemother. 47: 1391-1394.
23. Le Bras J, Deloron P, 1983. In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test. Am J Trop Med Hyg 32: 447-451.
24. Carlin JM, Vande Waa JA, Jensen JB, Akood MA, 1984. African serum interference in the determination of chloroquine sensitivity in Plasmodium falciparum. Z Parasitenkd 70: 589-597.
25. Denis MB, Davis TM, Hewitt S, Incardona S, Nimol K, Fandeur T, Poravuth Y, Lim C, Socheat D, 2002. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin Infect Dis 35: 1469-1476.
26. Karunajeewa H, Lim C, Hung TY, Ilett KF, Denis MB, Socheat D, Davis TM, 2004. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br J Clin Pharmacol 57: 93-99.